1,8,9-TRIHYDROXYANTHRACENE

Modify Date: 2025-08-24 19:42:26

1,8,9-TRIHYDROXYANTHRACENE Structure
1,8,9-TRIHYDROXYANTHRACENE structure
Common Name 1,8,9-TRIHYDROXYANTHRACENE
CAS Number 480-22-8 Molecular Weight 226.22700
Density N/A Boiling Point N/A
Molecular Formula C14H10O3 Melting Point 181 °C
MSDS N/A Flash Point N/A

 Names

Name anthracene-1,8,9-triol
Synonym More Synonyms

 Chemical & Physical Properties

Melting Point 181 °C
Molecular Formula C14H10O3
Molecular Weight 226.22700
Exact Mass 226.06300
PSA 60.69000
LogP 3.10980
Stability Stable. Combustible. Incompatible with strong oxidizing agents.

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CB1225000
CHEMICAL NAME :
1,8,9-Anthracenetriol
CAS REGISTRY NUMBER :
480-22-8
BEILSTEIN REFERENCE NO. :
1976792
LAST UPDATED :
199706
DATA ITEMS CITED :
27
MOLECULAR FORMULA :
C14-H10-O3
MOLECULAR WEIGHT :
226.24
WISWESSER LINE NOTATION :
L C666J BQ DQ NQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3216 mg/kg
TOXIC EFFECTS :
Gastrointestinal - ulceration or bleeding from small intestine Gastrointestinal - hypermotility, diarrhea Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
3 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - muscle weakness Lungs, Thorax, or Respiration - dyspnea
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1542 mg/kg
TOXIC EFFECTS :
Gastrointestinal - ulceration or bleeding from small intestine Gastrointestinal - hypermotility, diarrhea Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
509 mg/kg/53W-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
73 mg/kg/11W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
240 mg/kg/50W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
Mutation test systems - not otherwise specified
TYPE OF TEST :
Mutation test systems - not otherwise specified

MUTATION DATA

TYPE OF TEST :
Cytogenetic analysis
TEST SYSTEM :
Rodent - hamster Fibroblast
DOSE/DURATION :
100 ug/L
REFERENCE :
CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 3,499,1982 *** REVIEWS *** IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 13,75,1977 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 13,75,1977 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987 TOXICOLOGY REVIEW ZKKOBW Zeitschrift fuer Krebsforschung und Klinische Onkologie. (Berlin, Fed. Rep. Ger.) V.76-92, 1971-78. For publisher information, see JCROD7. Volume(issue)/page/year: 78,99,1972

 Safety Information

Risk Phrases R36/37/38
Safety Phrases S26-S36
WGK Germany 3
RTECS CB8927000
HS Code 2907299090

 Synthetic Route

~%

1,8,9-TRIHYDROXYANTHRACENE Structure

1,8,9-TRIHYDROX...

CAS#:480-22-8

Literature: Schrobsdorff Chemische Berichte, 1902 , vol. 35, p. 2930

 Precursor & DownStream

Precursor  1

DownStream  0

 Customs

HS Code 2907299090
Summary 2907299090 polyphenols; phenol-alcohols。supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward)。VAT:17.0%。tax rebate rate:9.0%。MFN tariff:5.5%。general tariff:30.0%

 Synonyms

1,8,9-Trihydroxyanthracene
MFCD00001250
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here



Get all suppliers and price by the below link:

1,8,9-TRIHYDROXYANTHRACENE suppliers

1,8,9-TRIHYDROXYANTHRACENE price

Related Compounds: More...
1,8,9-Trihydroxyanthracene
1143-38-0
3-Methyl-1,8,9-trihydroxyanthracene
491-59-8
1,8,9,10,11,12-hexahydrotricyclo[6.2.2.02,7]dodeca-3,9-dien-3-ol
52960-97-1
1,8,9,10-tetrahydrotricyclo[6.2.2.02,7]dodeca-3,9-diene-3,6-dione
91368-37-5
1-(1,8,9,10,11,12-hexahydrotricyclo[6.2.2.02,7]dodeca-3,9-dien-9-yl)piperidine
138648-45-0
tetramethyl hexadecane-1,8,9,16-tetracarboxylate
144190-29-4
tetracyclo<6.4.0.12.5.04.7>trideca-1(8),9,11-triene-2,7-dicarbonitrile
102359-62-6
3,6-dimethoxy-1,8,9,10-tetrahydrotricyclo[6.2.2.02,7]dodeca-3,9-diene
17547-70-5
(E)-but-2-enedioic acid,1-(8,9-dihydro-7H-benzo[7]annulen-7-yl)pyrrolidine
62819-73-2
rac-(3R,5R)-5-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetamido]methyl}oxolane-3-carboxylic acid
2227862-36-2
rac-(3R,5R)-5-{[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)but-2-enamido]methyl}oxolane-3-carboxylic acid
2227685-05-2
3-{[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)but-2-ynamido]methyl}cyclohexane-1-carboxylic acid
2171806-04-3
rac-(3R,5R)-5-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2-methylbutanamido]methyl}oxolane-3-carboxylic acid
2228073-87-6
rac-(3R,5R)-5-{[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,2-dimethylpropanamido]methyl}oxolane-3-carboxylic acid
2227863-02-5
rac-(3R,5R)-5-{[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanamido]methyl}oxolane-3-carboxylic acid
2227933-91-5
3-{[3-(benzyloxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]methyl}cyclohexane-1-carboxylic acid
2171746-37-3
5-{[(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]methyl}oxolane-3-carboxylic acid
2171415-16-8
rac-2-{1-[(1R,2S)-2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopropyl]-N-propylformamido}acetic acid
2227862-51-1
rac-2-{1-[(1R,2S)-2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]cyclopropyl]-N-methylformamido}butanoic acid
2227927-68-4